Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Lyudmila V ParfenovaInstitute of Petrochemistry and Catalysis, Ufa Federal Research Center, Russian Academy of Sciences, Prospekt Oktyabrya, 141, 450075 Ufa, Russia.ORCID 0000-0003-2816-2178
Eliza I AlibaevaInstitute of Petrochemistry and Catalysis, Ufa Federal Research Center, Russian Academy of Sciences, Prospekt Oktyabrya, 141, 450075 Ufa, Russia.ORCID 0000-0003-3144-300X
Guzel U Gil'fanovaInstitute of Petrochemistry and Catalysis, Ufa Federal Research Center, Russian Academy of Sciences, Prospekt Oktyabrya, 141, 450075 Ufa, Russia.ORCID 0000-0001-5559-2187
Zulfiya R GalimshinaInstitute of Petrochemistry and Catalysis, Ufa Federal Research Center, Russian Academy of Sciences, Prospekt Oktyabrya, 141, 450075 Ufa, Russia.ORCID 0000-0003-0037-9930
Ekaterina S MescheryakovaInstitute of Petrochemistry and Catalysis, Ufa Federal Research Center, Russian Academy of Sciences, Prospekt Oktyabrya, 141, 450075 Ufa, Russia.
Leonard M KhalilovInstitute of Petrochemistry and Catalysis, Ufa Federal Research Center, Russian Academy of Sciences, Prospekt Oktyabrya, 141, 450075 Ufa, Russia.ORCID 0000-0002-2095-9097
Semen N SergeevDepartment of Materials Science and Physics of Metals, Institute of Technology and Materials, Ufa University of Science and Technology, 12 Karl Marx Street, 450008 Ufa, Russia.ORCID 0000-0001-5494-390X
Nikita V PenkovInstitute of Cell Biophysics of the Russian Academy of Sciences, Federal Research Center "Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences", Institutskaya 3, 142290 Pushchino, Russia.ORCID 0000-0003-2212-5640
Baoqiang LiState Key Laboratory of Urban Water Resource and Environment, Institute for Advanced Ceramics, Harbin Institute of Technology, Harbin 150001, China.ORCID 0000-0003-0278-4542
Funding
Russian Science Foundation 23-73-00024
6 · The paper itself
Abstract
Gold nanoparticles (AuNPs) are promising for biomedical applications, but their synthesis often requires toxic reagents. "Green" methods utilizing biopolymers offer a sustainable alternative. This study presents a novel synthesis of stable gold nanoparticles using a disulfide-crosslinked derivative of alginic acid (AA-S-S-AA) as both a reducing agent and stabilizer. The S-S-cross-linked alginate was synthesized with a degree of substitution of ~4.2% and reacted with HAuCl
Indexed as
alginic acidAu nanoparticlesin situ modified with alginatesize stability
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Reductive Synthesis of Stable, Polysaccharide in Situ-Modified Gold Nanoparticles Using Disulfide Cross-Linked Alginate. · full record | OpenQuestion